NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

At this point, the bread crumbs are everywhere. The CRL acquisition was a very significant indicator that this stage is coming to a close.

How strong TLD is anyone’s guess, but it’s almost certain to be successful enough as not to leave any doubt. There’s just too much investment and lining up of resources by the stakeholders.

If the trial failed or the results were far below expectations, then how do you explain everything else they have been doing? Why rush the completion of Sawston? Why buy Flaskworks? Why gear up for production of a treatment that will never be approved? ]